Cleerly, coronary artery disease,

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in the United States. In fact, the AHA reports more than 930,000 people died of coronary heart diseasein 20211.

March 10, 2026 — Medtronic has entered into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative technology across the neurovascular portfolio.

cardiac ultrasound, cardiac imaging

The demand for ultrasound has outpaced the supply of trained sonographers over the past 15 years, straining hospital resources and creating delays in care.1 One of the most affected areas is the echocardiography (echo) lab, where access to echocardiograms is often limited by staffing shortages.
Tags
cardiac ultrasound

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the deployment of its AI imaging platform, Brainomix 360 Stroke, throughout the West Virginia University (WVU) Health System network. All 25 sites across the network now have access to a unified AI solution designed to support consistent diagnostic assessment and timely treatment for stroke.

March 10, 2026 — HeartHero has announced that its Premarket Approval (PMA) application for Elliot, the company’s connected Automated External Defibrillator (AED), has been submitted to and accepted for review by the U.S. Food and Drug Administration (FDA). Elliot is regulated as a Class III medical device, the FDA’s highest-risk and most rigorously evaluated category for life-sustaining technologies.

March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an AI-powered cardiac MR planning solution designed to simplify one of the most technically demanding MRI exams. SmartHeart automates the planning process in under 30 seconds, helping make cardiac MR more consistent and accessible.

One-click Planning 

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as HeartBeam’s first commercial customer, ClearCardio also plans to make an investment in HeartBeam, reflecting strong strategic alignment.

March 2, 2026 — Ascend Cardiovascular has launched its re-imagined pediatric cardiology product, a comprehensive solution specifically designed to meet the unique, lifelong demands of congenital heart disease (CHD) care — from fetal through adulthood. By combining modernized Mullins diagrams with an integration-first architecture, ASCEND is ending the era of “good enough” legacy systems for pediatric programs. 

March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps across three of the most costly and prevalent cardiovascular conditions: abdominal aortic aneurysm (AAA), heart failure and coronary artery calcification (CAC). The expansion represents a step-change evolution of the Inflo platform as an enterprise care orchestration layer, expanding patient management capacity across diagnostic insights.

Cardiology Orchestration

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now